ESPRESSO CLINIC LTD

Company Registration Number:
11988073 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 01 June 2022

End date: 31 May 2023

ESPRESSO CLINIC LTD

Contents of the Financial Statements

for the Period Ended 31 May 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

ESPRESSO CLINIC LTD

Company Information

for the Period Ended 31 May 2023




Director: Bartosz Pradzynski
Registered office: Unit 3
Unit 3
1 Emma Street
London
Tower Hamlets
England
Company Registration Number: 11988073 (England and Wales)

ESPRESSO CLINIC LTD

Balance sheet

As at 31 May 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 38,142 22,637
Total fixed assets: 38,142 22,637
Current assets
Debtors: 5 2,705 465
Cash at bank and in hand: 37,347 26,851
Total current assets: 40,052 27,316
Creditors: amounts falling due within one year: 6 ( 50,998 ) ( 21,895 )
Net current assets (liabilities): ( 10,946 ) 5,421
Total assets less current liabilities: 27,196 28,058
Creditors: amounts falling due after more than one year: 7 ( 14,352 ) ( 19,676 )
Total net assets (liabilities): 12,844 8,382

The notes form part of these financial statements

ESPRESSO CLINIC LTD

Balance sheet continued

As at 31 May 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 12,744 8,282
Shareholders funds: 12,844 8,382

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 7 January 2024
And Signed On Behalf Of The Board By:

Name: Bartosz Pradzynski
Status: Director

The notes form part of these financial statements

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    The turnover shown in the profit and loss account represent revenue recognised by the company, in respect of service supplied during the period, exclusive of Value Added Tax

    Tangible fixed assets depreciation policy

    Depreciation is provided, after taking accounts of any grants, of each asset over its estimated useful life.

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 1 1

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 3. Off balance sheet disclosure

    No

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

4. Tangible assets

Plant & machinery Office equipment Motor vehicles Total
Cost £ £ £ £
At 01 June 2022 7,193 11,789 7,495 26,477
Additions 21,113 2,053 - 23,166
Disposals - - - -
Revaluations - - - -
Transfers - - - -
At 31 May 2023 28,306 13,842 7,495 49,643
Depreciation
At 01 June 2022 270 1,322 2,248 3,840
Charge for year 1,969 4,568 1,124 7,661
On disposals - - - -
Other adjustments - - - -
At 31 May 2023 2,239 5,890 3,372 11,501
Net book value
At 31 May 2023 26,067 7,952 4,123 38,142
At 31 May 2022 6,923 10,467 5,247 22,637

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

5. Debtors


2023
£

2022
£
Trade debtors 2,705 465
Total 2,705 465

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

6.Creditors: amounts falling due within one year note


2023
£

2022
£
Bank loans and overdrafts 14,450 3,626
Trade creditors 33,810 15,629
Taxation and social security 2,738 2,640
Total 50,998 21,895

ESPRESSO CLINIC LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

7.Creditors: amounts falling due after more than one year


2023
£

2022
£
Bank loans and overdrafts 14,352 19,676
Total 14,352 19,676